Lexicon Pharmaceuticals Inc (LXRX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.83B
EV to revenue ratio (TTM)
18.30
EV to ebitda
16.57
Financial Performance
Revenue (TTM)
$0.04B
Gross profit (TTM)
$0.04B
EBITDA
-$0.06B
Profitability
Operating margin (TTM)
-147.40%
Profit margin
-161.80%
Return on assets (TTM)
-15.90%
Return on equity (TTM)
-43.90%
Per Share Metrics
Revenue per share (TTM)
$0.09
EPS
-$0.15
Diluted EPS (TTM)
-$0.15
Book value
$0.37
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
-0.14
Price to sales ratio (TTM)
21.60
Price to book ratio (TTM)
5.10
Growth
Quarterly earnings growth (YoY)
-20.70%
Quarterly revenue growth (YoY)
-63.40%
Analyst Sentiment
Strong buy
1
Buy
3
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.08